These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2050321)

  • 21. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
    Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G
    Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term treatment of chronic delta hepatitis with alpha recombinant interferon.
    Marinucci G; Hassan G; Di Giacomo C; Barlattani A; Costa F; Rasshofer R; Roggendorf M
    Prog Clin Biol Res; 1991; 364():405-10. PubMed ID: 2020716
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of chronic hepatitis C with recombinant interferon alfa.
    Cimino L; Nardone G; Citarella C; Perna E; Capuano G; Budillon G
    Ital J Gastroenterol; 1991; 23(7):399-402. PubMed ID: 1742537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response.
    Madejón A; Cotonat T; Bartolomé J; Castillo I; Carreño V
    Hepatology; 1994 Jun; 19(6):1331-6. PubMed ID: 8188163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged alpha interferon therapy for chronic delta hepatitis: effect on liver histopathology.
    Kleiner D; Di Bisceglie AM; Axiotis CA; Hoofnagle JH
    Prog Clin Biol Res; 1993; 382():365-71. PubMed ID: 8502705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha interferon therapy of chronic delta hepatitis: a pilot study.
    Di Bisceglie AM; Negro F; Smedile A; Bergmann K; Hoofnagle JH
    Prog Clin Biol Res; 1991; 364():393-7. PubMed ID: 2020714
    [No Abstract]   [Full Text] [Related]  

  • 28. A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis.
    Yurdaydin C; Bozkaya H; Karaaslan H; Onder FO; Erkan OE; Yalçin K; Değertekin H; Bozdayi AM; Uzunalimoğlu O
    J Viral Hepat; 2007 Nov; 14(11):812-6. PubMed ID: 17927618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial.
    Gaudin JL; Faure P; Godinot H; Gerard F; Trepo C
    Liver; 1995 Feb; 15(1):45-52. PubMed ID: 7776857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
    Hoofnagle JH; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Peters M; Waggoner JG; Park Y; Jones EA
    N Engl J Med; 1986 Dec; 315(25):1575-8. PubMed ID: 3097544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment.
    Mederacke I; Yurdaydin C; Dalekos GN; Bremer B; Erhardt A; Cakaloglu Y; Yalcin K; Gurel S; Zeuzem S; Zachou K; Bozkaya H; Dienes HP; Manns MP; Wedemeyer H;
    Antivir Ther; 2012; 17(2):305-12. PubMed ID: 22293066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and treatment of hepatitis delta virus infection.
    Karayiannis P; Saldanha J; Monjardino J; Farci P; Thomas HC
    Prog Clin Biol Res; 1991; 364():377-83. PubMed ID: 2020712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term interferon treatment of chronic delta hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Prog Clin Biol Res; 1991; 364():385-91. PubMed ID: 2020713
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
    Craxì A; Di Marco V; Volpes R; Marra S; Rizzetto M; Rosina F; Barbera C; Bortolotti F; Crivellaro C; Iannuzzi C
    Prog Clin Biol Res; 1991; 364():399-404. PubMed ID: 2020715
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses.
    Porres JC; Carreño V; Bartolomé J; Moreno A; Galiana F; Quiroga JA
    J Hepatol; 1989 Nov; 9(3):338-44. PubMed ID: 2691569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
    Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
    Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.
    Farci P; Roskams T; Chessa L; Peddis G; Mazzoleni AP; Scioscia R; Serra G; Lai ME; Loy M; Caruso L; Desmet V; Purcell RH; Balestrieri A
    Gastroenterology; 2004 Jun; 126(7):1740-9. PubMed ID: 15188169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of chronic hepatitis D with interferon alfa-2a.
    Farci P; Mandas A; Coiana A; Lai ME; Desmet V; Van Eyken P; Gibo Y; Caruso L; Scaccabarozzi S; Criscuolo D
    N Engl J Med; 1994 Jan; 330(2):88-94. PubMed ID: 8259188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial.
    Sáez-Royuela F; Porres JC; Moreno A; Castillo I; Martinez G; Galiana F; Carreño V
    Hepatology; 1991 Feb; 13(2):327-31. PubMed ID: 1899852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study.
    Ruiz-Moreno M; Rua MJ; Castillo I; García-Novo MD; Santos M; Navas S; Carreño V
    Hepatology; 1992 Oct; 16(4):882-5. PubMed ID: 1328009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.